Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

European Urology
Florian JentzmikKlaus Jung

Abstract

Sarcosine in urine was recently suggested to be a promising tool in prostate cancer (PCa) diagnostics. To reevaluate sarcosine as a potential biomarker for early PCa detection and for prediction of tumour aggressiveness. Sarcosine was measured in urine samples from 106 PCa patients and 33 patients with no evidence of malignancy (NEM), confirmed by 8-12 core prostate biopsies, after standardised digital rectal examination, as well as from 12 healthy men and women. The results were related to the clinicopathologic data on prostate volume, tumour stage, Gleason score, and prostate specific antigen (PSA). Sarcosine in urine was determined by gas chromatography-mass spectrometry using a commercial amino acid assay and was normalised to urine creatinine. Nonparametric statistical tests and receiver operating characteristics (ROC) analyses were performed to assess the diagnostic performance. The median sarcosine-creatinine ratio in urine was 13% lower in PCa than in NEM patients. Sarcosine values were not associated with tumour stage (pT2 vs pT3) or grade (Gleason score <7 vs > or = 7). ROC analyses proved that the discrimination between PCa and NEM patients was not improved by sarcosine in comparison with total PSA, but it was signif...Continue Reading

References

May 8, 2003·Journal of the National Cancer Institute·Michael W Kattan
Dec 7, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Lori J SokollRobert L Vessella
Feb 26, 2008·The Journal of Urology·Ina L DerasJack Groskopf
Nov 15, 2008·Molecular & Cellular Proteomics : MCP·Kyoungmi KimRobert H Weiss
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer L SpratlinS Gail Eckhardt
Mar 13, 2009·JAMA : the Journal of the American Medical Association·Bridget M Kuehn

❮ Previous
Next ❯

Citations

Oct 19, 2010·Archives of Toxicology·Mamas MamasRoyston Goodacre
Jul 15, 2011·Molecular Biology Reports·Malin DahlKirsten Bouchelouche
Aug 7, 2013·Journal of Pharmaceutical and Biomedical Analysis·Helen G GikaIan D Wilson
Apr 6, 2012·Journal of the American Chemical Society·Marco DionisioEnrico Dalcanale
Jul 5, 2013·Nature Reviews. Cancer·Jason W Locasale
Mar 3, 2011·Nature Reviews. Clinical Oncology·Samir M HanashOlli Kallioniemi
Feb 16, 2011·Omics : a Journal of Integrative Biology·John R Masters
Feb 26, 2011·Omics : a Journal of Integrative Biology·Kyoungmi KimRobert H Weiss
Jan 31, 2012·Briefings in Bioinformatics·Jinlian WangHabtom W Ressom
Jul 25, 2013·International Journal of Molecular Sciences·Natalia CerneiVojtech Adam
Sep 29, 2011·Bioanalysis·Sanjeewa Gamagedara, Yinfa Ma
Oct 11, 2012·Bioanalysis·Stuart SnowdenCraig E Wheelock
Mar 8, 2012·Bioanalysis·Thomas M O'Connell
Aug 25, 2012·Biomarkers in Medicine·Makito MiyakeCharles J Rosser
Jul 17, 2013·Journal of Carcinogenesis·Kathleen A Vermeersch, Mark P Styczynski
Feb 6, 2014·Endocrine-related Cancer·Stefan J BarfeldIan G Mills
May 17, 2014·Asian Journal of Andrology·Min QuYing-Hao Sun
Apr 9, 2013·Biological Psychiatry·Chih-Chia HuangGuochuan Emil Tsai
Dec 27, 2011·Urology·Andrew J Vickers, Hans Lilja
Sep 21, 2011·Urologic Oncology·Bruce J Trock
Dec 21, 2010·The Journal of Urology·Conrad Wagner, Zigmund Luka
Nov 29, 2015·The Urologic Clinics of North America·Jeffrey J TosoianChristian P Pavlovich
Jul 5, 2013·The Prostate·Jonathan E McDunnThomas M Wheeler
Jun 10, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Monica KhungerAshish K Tiwari
Sep 12, 2015·Future Oncology·Carsten StephanBernhard Ralla
Oct 3, 2015·BMC Urology·Donna P AnkerstRobin J Leach
Apr 12, 2016·Cancer Chemotherapy and Pharmacology·Ali Aboel DahabNorman W Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.